USK-17249-21728 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-02
Dose 1 — Pfizer-BioNTech
2021-04-19
Registered in v-safe
2021-04-19
Survey response — day 14, dose 1
MedDRA: Dizziness, Headache, Hypoaesthesia, Vitreous floaters — Feeling: Fair · Be unable to do your normal daily activities

Free text: Headaches lasting for weeks , dizziness , floaters, numbness in body

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-19
Report sent to call center — day 14, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-04-24
Dose 2 — Pfizer-BioNTech
2021-04-24
Survey response — day 0, dose 2
MedDRA: Dysgeusia — Feeling: Fair · Site: Pain · Joint pains

Free text: Metallic taste of mouth

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-25
Survey response — days 1–6 daily, dose 2
MedDRA: Chest pain — Feeling: Fair · Site: Pain

Free text: Chest pain

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-30
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-02	Pfizer-BioNTech
2	2021-04-24	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-04-19	priority 2/3

Free text

Release 7 — day 14, dose 1

2021-04-19

Symptoms: Headaches lasting for weeks , dizziness , floaters, numbness in body

Release 7 — day 0, dose 2

2021-04-24

Systemic reaction (other): Metallic taste of mouth

Release 7 — days 1–6 daily, dose 2

2021-04-25

Systemic reaction (other): Chest pain

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Dizziness	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Hypoaesthesia	✓	✓	✓
SD	Vitreous floaters	✓	✓	✓
SRO	Chest pain	✓	✓	✓
SRO	Dysgeusia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release